DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $510,000 | -28.7% | 55,000 | -24.9% | 0.01% | 0.0% |
| Q4 2021 | $715,000 | -87.6% | 73,200 | -56.9% | 0.01% | -91.1% |
| Q3 2021 | $5,777,000 | -36.2% | 170,000 | -31.3% | 0.08% | -27.5% |
| Q2 2021 | $9,061,000 | -12.1% | 247,500 | +7.6% | 0.11% | -14.2% |
| Q1 2021 | $10,313,000 | -55.9% | 230,000 | -43.9% | 0.13% | +0.8% |
| Q4 2020 | $23,398,000 | +128.1% | 410,000 | +105.0% | 0.13% | -17.6% |
| Q3 2020 | $10,260,000 | -18.2% | 200,000 | -4.8% | 0.15% | -30.1% |
| Q2 2020 | $12,541,000 | +90.4% | 210,000 | +31.2% | 0.22% | +32.7% |
| Q1 2020 | $6,587,000 | -21.6% | 160,000 | +18.5% | 0.16% | -11.8% |
| Q4 2019 | $8,402,000 | -6.6% | 135,000 | -49.1% | 0.19% | -24.6% |
| Q3 2019 | $8,994,000 | +62.8% | 265,000 | +8.2% | 0.25% | +95.3% |
| Q2 2019 | $5,525,000 | +81.3% | 245,000 | +86.6% | 0.13% | +225.6% |
| Q1 2019 | $3,047,000 | +21.6% | 131,295 | +5.0% | 0.04% | -25.0% |
| Q1 2018 | $2,505,000 | -49.8% | 125,000 | -43.2% | 0.05% | -51.4% |
| Q4 2017 | $4,987,000 | +31.3% | 220,000 | +10.0% | 0.11% | +13.8% |
| Q3 2017 | $3,798,000 | – | 200,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |